HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer.

Abstract
The currently available medical treatment options of adrenocortical cancer (ACC) are limited. In our previous meta-analysis of adrenocortical tumor genomics data, ACC was associated with reduced retinoic acid production and retinoid X receptor-mediated signaling. Our objective has been to study the potential antitumoral effects of 9-cis retinoic acid (9-cisRA) on the ACC cell line NCI-H295R and in a xenograft model. Cell proliferation, hormone secretion, and gene expression have been studied in the NCI-H295R cell line. A complex bioinformatics approach involving pathway and network analysis has been performed. Selected genes have been validated by real-time qRT-PCR. Athymic nude mice xenografted with NCI-H295R have been used in a pilot in vivo xenograft model. 9-cisRA significantly decreased cell viability and steroid hormone secretion in a concentration- and time-dependent manner in the NCI-H295R cell line. Four major molecular pathways have been identified by the analysis of gene expression data. Ten genes have been successfully validated involved in: (1) steroid hormone secretion (HSD3B1, HSD3B2), (2) retinoic acid signaling (ABCA1, ABCG1, HMGCR), (3) cell-cycle damage (GADD45A, CCNE2, UHRF1), and the (4) immune response (MAP2K6, IL1R2). 9-cisRA appears to directly regulate the cell cycle by network analysis. 9-cisRA also reduced tumor growth in the in vivo xenograft model. In conclusion, 9-cisRA might represent a promising new candidate in the treatment of hormone-secreting adrenal tumors and adrenocortical cancer.
AuthorsDiana Rita Szabó, Kornélia Baghy, Peter M Szabó, Adrienn Zsippai, István Marczell, Zoltán Nagy, Vivien Varga, Katalin Éder, Sára Tóth, Edit I Buzás, András Falus, Ilona Kovalszky, Attila Patócs, Károly Rácz, Peter Igaz
JournalCellular and molecular life sciences : CMLS (Cell Mol Life Sci) Vol. 71 Issue 5 Pg. 917-32 (Mar 2014) ISSN: 1420-9071 [Electronic] Switzerland
PMID23807211 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Gonadal Steroid Hormones
  • Alitretinoin
  • Tretinoin
Topics
  • Adrenal Cortex Neoplasms (drug therapy)
  • Alitretinoin
  • Animals
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Computational Biology (methods)
  • Gene Expression Regulation, Neoplastic (drug effects, immunology, physiology)
  • Gonadal Steroid Hormones (metabolism)
  • Humans
  • Mice
  • Mice, Nude
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction (drug effects, physiology)
  • Tretinoin (pharmacology, therapeutic use)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: